Embozene(TM) Microspheres are the first and only microspheres to be color- enhanced with a different color for each size for increased procedural safety, efficiency and visibility. They are also available in a wider range of sizes than any other spherical embolic on the market. They are available in 40, 100, 250, 400, 500, 700, and 900 micron sizes in 1 ml and 2 ml pre-filled syringes and vials.
CeloNova's Embozene(TM) Microspheres consist of a hydrogel core and an exterior shell made from Polyzene(R)-F, CeloNova's proprietary polymer which is known to be anti-inflammatory and bacterial-resistant. Four design features distinguish Embozene(TM) Microspheres from other spherical embolics: biocompatibility, precise calibration, stable suspension, and structural stability. Embozene(TM) Microspheres are precisely calibrated, they retain their shape after passing through a catheter, and they can stay in suspension for an extended time. The unique color enhancement of the microspheres and finely calibrated sizes make selection easy, efficient, and precise for the operator. The result is an embolic microsphere that provides accurate and complete vessel occlusion.
"Dr. Lipman is a recognized leader in embolization therapy and we are
extremely pleased that he was the first U.S. physician to implant our newly
approved Embozene(TM) Microspheres with such wonderful results," said Thomas A.
Gordy, President and Chief Executive Officer, CeloNova BioSciences, Inc.
"From the outset, we took a different approach to developing our Embozene(TM)
Microspheres by asking physicians and medical scientists for the qualities and
characteristics that the ideal embolic device should have. Then, we engineered
in those properties physicians wanted and engineered out those properties th
|SOURCE CeloNova BioSciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved